Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations

Journal of Alzheimer's Disease : JAD
Andrea ArighiDaniela Galimberti

Abstract

A hexanucleotide repeat expansion in the first intron of C9ORF72 has been shown to be responsible for a high number of familial cases of amyotrophic lateral sclerosis or frontotemporal lobar degeneration with or without concomitant motor neuron disease phenotype and TDP-43 based pathology. Here, we report on three cases carrying the hexanucleotide repeat expansion with an atypical presentation consisting in the development of psychiatric symptoms. Patient #1, a 53 year old man with positive family history for dementia, presented with mood deflection, characterized by apathy, social withdraw, and irritability in the last two years. He was diagnosed with "mild cognitive impairment due to depressive syndrome" six months later and subsequently with Alzheimer's disease. Patient #2, a woman with positive family history for dementia, developed behavioral disturbances, aggressiveness, and swearing at 57 years of age. Patient #3 presented, in the absence of brain atrophy, with mystical delirium with auditory hallucinations at 44 years of age, and did not present neurological symptoms over a 7-year follow up. The description of these cases underlines that the hexanucleotide repeat expansion in chromosome 9 could be associated with early ...Continue Reading

Citations

Aug 15, 2012·Acta Neuropathologica·Anne SiebenMarc Cruts
Oct 8, 2013·Acta Neuropathologica·Ian R MackenzieManuela Neumann
Aug 13, 2013·Molecular Neurobiology·Ying LiuLan Tan
Sep 22, 2015·Frontiers in Aging Neuroscience·Alberto BenussiBarbara Borroni
Nov 1, 2012·Human Mutation·Julie van der ZeeUNKNOWN European Early-Onset Dementia Consortium
Nov 28, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Juan F Vázquez-CostaTeresa Sevilla
Dec 26, 2016·Journal of Genetic Counseling·Jill S GoldmanDeborah Z Thorne
Apr 20, 2013·Translational Neurodegeneration·Xiao-Dong Pan, Xiao-Chun Chen
Feb 12, 2014·Acta Neuropathologica·Ione O C Woollacott, Simon Mead
Feb 14, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Laura E DowneyJason D Warren
Mar 12, 2016·Journal of Alzheimer's Disease : JAD·Estrella Gómez-TortosaMaría José Sainz
Jan 21, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Estrella Gómez-TortosaM José Sainz
Jun 6, 2020·The Journal of Neuropsychiatry and Clinical Neurosciences·Mario F MendezGolnoush Akhlaghipour
Jul 29, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Serggio C Lanata, Bruce L Miller
Feb 5, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Chiara Cerami, Stefano F Cappa
Apr 5, 2013·Bipolar Disorders·Miriam H MeislerMelvin G McInnis
May 5, 2016·Journal of Neurochemistry·Ione O C Woollacott, Jonathan D Rohrer
May 27, 2015·Current Neurology and Neuroscience Reports·Devin Hall, Elizabeth C Finger
Jan 29, 2017·Cold Spring Harbor Perspectives in Medicine·Ilse GijselinckChristine Van Broeckhoven
Jun 18, 2019·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Leila SellamiRobert Laforce
Jan 7, 2021·JAMA Network Open·Alberto BenussiUNKNOWN Genetic FTD Initiative (GENFI)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.